...
首页> 外文期刊>Journal of cardiothoracic and vascular anesthesia >Anesthetic management for a patient with transcatheter mitral valve implantation
【24h】

Anesthetic management for a patient with transcatheter mitral valve implantation

机译:经导管二尖瓣植入术患者的麻醉管理

获取原文
获取原文并翻译 | 示例

摘要

MITRAL VALVE REDO OPERATIONS due to failing bioprostheses are known to be associated with high rates of morbidity and mortality. Transcatheter mitral valve implantation (TMVI) procedures in high-risk patients with severe mitral regurgitation have become a promising treatment option. We report a new transcatheter technique as an alternative to redo operations in patients with degenerative mitral valve bioprosthesis. There are a limited number of studies on the use of this technique. The main objective of the administration of anesthesia for TMVI application is to maintain hemodynamic stability. In this report, the authors present the anesthesia management of TMVI for a 79-year-old female patient with severe mitral valve regurgitation resulting from a degenerative mitral bioprosthetic valve. Although a standard method of anesthesia in this high-risk group of patients has not yet been established, the authors prefer general anesthesia because it provides airway safety in cases of pulmonary edema and facilitates the implementation of transesophageal echocardiography (TEE).
机译:由于生物假体失败,二尖瓣再手术操作与高发病率和高死亡率有关。高危二尖瓣关闭不全的高危患者经导管二尖瓣植入术(TMVI)已成为一种有前途的治疗选择。我们报告了一种新的经导管技术,作为变性二尖瓣生物假体患者重做手术的替代方法。关于这种技术的使用的研究有限。为TMVI应用进行麻醉的主要目的是维持血液动力学稳定性。在本报告中,作者介绍了由变性二尖瓣生物人工瓣膜导致的严重二尖瓣返流的79岁女性患者的TMVI麻醉管理。尽管尚未建立针对这种高风险患者的标准麻醉方法,但作者更喜欢全身麻醉,因为它在肺水肿的情况下可提供气道安全性,并有助于实施经食道超声心动图(TEE)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号